Sugi Predict

Sugi Predict / Compounds / SCHEMBL7160402

SCHEMBL7160402

SCHEMBL7160402

Oc1cc(Br)c(F)cc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 4/20 0.46
▸ HSD17B10 Q99714 4/20 0.46
▸ HPGD P15428 2/20 0.46
▸ KDM1A O60341 3/20 0.40
▸ KDM1B Q8NB78 3/20 0.40
▸ CYP3A4 P08684 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ ADRA1A P35348 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ ESR1 P03372 1/20 0.33
▸ ESR2 Q92731 1/20 0.33
▸ HSP90AA1 P07900 1/20 0.32
▸ ACLY P53396 1/20 0.32
▸ HSD17B1 P14061 1/20 0.32
▸ HSD17B2 P37059 1/20 0.32
▸ KCNH2 Q12809 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3405663 0.91 TSHR (0.46) TSHRHSD17B10HPGDKDM1AKDM1B
SCHEMBL23706575 0.81 AHR (0.39) TSHRHSD17B10HPGDKDM1AKDM1B
SCHEMBL32675747 0.81 AHR (0.39) TSHRHSD17B10HPGDKDM1AKDM1B
SCHEMBL1697562 0.79 ALOX15 (0.38) TSHRHSD17B10KDM1AKDM1BCYP3A4
SCHEMBL1479085 0.79 KDM1A (0.50) KDM1AKDM1BALDH1A1TDP1NPC1
SCHEMBL30826229 0.79 KDM1A (0.50) KDM1AKDM1BALDH1A1TDP1NPC1
SCHEMBL18893969 0.79 HSD17B10 (0.55) TSHRHSD17B10HPGDCYP3A4ALDH1A1
SCHEMBL30687171 0.79 ALOX15 (0.38) TSHRHSD17B10KDM1AKDM1BCYP3A4
SCHEMBL2916768 0.77 CA3 (0.40) TSHRKDM1AKDM1BCYP3A4TDP1
SCHEMBL31357885 0.77 TSHR (0.60) TSHRHSD17B10HPGDKDM1AKDM1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117736222-A MTA synergistic PRMT5 inhibitor compounds having tricyclic or tetracyclic ring structures 烨辉医药科技(上海)有限公司 2024-03-22 — — CN disclosed
WO-2023009816-A1 HETEROARYL COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE PTC THERAPEUTICS, INC. (US) 2023-02-02 — — WO disclosed
CN-112300132-A Aryl quinazoline DNA-PK inhibitor 山东轩竹医药科技有限公司 2021-02-02 — — CN disclosed
US-9708534-B2 Polymerizable compound having triple bond, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2017-07-18 — — US disclosed
US-9708534-B2 Polymerizable compound having triple bond, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2017-07-18 — — US disclosed
US-9663508-B2 Biaryl acyl-sulfonamide compounds as sodium channel inhibitors AMGEN INC. (US) 2017-05-30 — — US disclosed
US-9663508-B2 Biaryl acyl-sulfonamide compounds as sodium channel inhibitors AMGEN INC. (US) 2017-05-30 — — US disclosed
US-9580444-B2 Polycyclic pyrazolinone derivative and herbicide comprising same as effective component thereof SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) 2017-02-28 — — US disclosed
US-9580444-B2 Polycyclic pyrazolinone derivative and herbicide comprising same as effective component thereof SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) 2017-02-28 — — US disclosed
US-9580444-B2 Polycyclic pyrazolinone derivative and herbicide comprising same as effective component thereof SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) 2017-02-28 — — US disclosed
US-20150376505-A1 POLYMERIZABLE COMPOUND HAVING TRIPLE BOND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC PETROCHEMICAL CORPORATION (JP) 2015-12-31 — — US disclosed
WO-2014142307-A1 POLYCYCLIC PYRAZOLINONE DERIVATIVE AND HERBICIDE COMPRISING SAME AS EFFECTIVE COMPONENT THEREOF 公益財団法人相模中央化学研究所 (JP) 2014-09-18 — — WO disclosed
CN-1205151-C Halogenation of protected phenols in meta position RHODIA CHIMIE SA (FR) 2005-06-08 — — CN disclosed
US-6576782-B1 Halogenation of protected phenols in meta position RHODIA CHIMIE (FR) 2003-06-10 — — US disclosed
CN-1348433-A Halogenation of protected phenols in meta position RHODIA CHIMIE SA (FR) 2002-05-08 — — CN disclosed
EP-1165466-A1 HALOGENATION OF PROTECTED PHENOLS IN META POSITION Rhodia Chimie (FR) 2002-01-02 — — EP disclosed
WO-2000061523-A1 HALOGENATION OF PROTECTED PHENOLS IN META POSITION RHODIA CHIMIE (FR) 2000-10-19 — — WO disclosed
US-6054413-A AGRICULTURE, HORTICULTURE BASF AKTIENGESELLSCHAFT (DE) 2000-04-25 — — US disclosed
EP-0931072-A1 1-SULFONYL-3-PHENYLPYRAZOLES AND THEIR USE AS HERBICIDES AND FOR DESICCATING OR DEFOLIATING PLANTS BASF AKTIENGESELLSCHAFT (DE) 1999-07-28 — — EP disclosed
WO-1998012182-A1 1-SULFONYL-3-PHENYLPYRAZOLES AND THEIR USE AS HERBICIDES AND FOR DESICCATING OR DEFOLIATING PLANTS BASF AKTIENGESELLSCHAFT (DE) 1998-03-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150376505-A1 POLYMERIZABLE COMPOUND HAVING TRIPLE BOND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE CCNT1, CCNA1, CCND1 TSHR 4522/4885HSD17B10 2114/4885HPGD 3522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.